In this issue:
Use of Schedule II stimulants in US database
Probiotics as an add on treatment
Efficacy and safety of psilocybin
Comparison of WET and PE treatments
Antidepressants as maintenance treatment
Safety and efficacy of evenamide
Treating MDD with zuranolone
Impacts of prenatal SSRI exposure on offspring
The effectiveness of antipsychotics and mood stabilisers
Vortioxetine versus desvenlafaxine in MDD patients
Please login below to download this issue (PDF)